NanoVibronix (NASDAQ:NAOV) Posts Earnings Results

NanoVibronix (NASDAQ:NAOV) issued its quarterly earnings data on Tuesday. The company reported ($3.98) earnings per share for the quarter, Zacks reports. NanoVibronix had a negative return on equity of 101.17% and a negative net margin of 93.80%.

NanoVibronix Stock Performance

Shares of NAOV stock opened at $1.29 on Wednesday. The firm has a market cap of $1.07 million, a P/E ratio of -1.05 and a beta of 2.03. NanoVibronix has a fifty-two week low of $1.15 and a fifty-two week high of $16.25. The business’s 50 day moving average price is $4.48 and its 200-day moving average price is $5.41.

NanoVibronix Company Profile

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.